Etarotene
Alternative Names: RO 151570Latest Information Update: 30 Nov 1995
At a glance
- Originator Roche
- Class Antipsoriatics; Small molecules
- Mechanism of Action Collagenase inhibitors; Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Psoriasis; Skin disorders
Most Recent Events
- 30 Nov 1995 Discontinued-III for Psoriasis in Switzerland (Topical)
- 30 Nov 1995 Discontinued-III for Skin disorders in Switzerland (Topical)